Inventor · disambiguated record
Rene De Waal Malefyt
Also filed as: DE WAAL MALEFYT RENE
40 granted patents·32 pending applications·451 citations·filing 1995–2024
98Inventor score
Top patents by PatentIndex Score
72 records- 0198US10188730B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME·Filed 2017·Granted Jan 29, 2019·42 cites·41 claims
- 0298US8232372B2Engineered anti-TSLP antibodyPRESTA LEONARD G·Filed 2007·Granted Jul 31, 2012·91 cites·12 claims
- 0394US7090847B1Mammalian cytokines; related reagents and methodsSCHERING CORP·Filed 2000·Granted Aug 15, 2006·69 cites·10 claims
- 0493US7183382B2Mammalian genes; related reagents and methodsSCHERING CORP·Filed 2003·Granted Feb 27, 2007·50 cites·22 claims
- 0590US11278620B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME·Filed 2018·Granted Mar 22, 2022·3 cites·8 claims
- 0689US7883695B2IL-12P40 and IL-B30 polypeptide complexSCHERING CORP·Filed 2006·Granted Feb 8, 2011·12 cites·3 claims
- 0789US6890734B2Nucleic acids encoding a cytokine receptor complexSCHERING CORP·Filed 2001·Granted May 10, 2005·16 cites·9 claims
- 0888US10898571B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME·Filed 2018·Granted Jan 26, 2021·2 cites·21 claims
- 0988US8475793B2Engineered anti-TSLPR antibodiesDE WAAL MALEFYT RENE·Filed 2009·Granted Jul 2, 2013·13 cites·4 claims
- 1088US6746670B2Regulatory T cells; methodsSCHERING CORP·Filed 2001·Granted Jun 8, 2004·27 cites·12 claims
- 1184US8076456B2Fusion proteins comprising canine thymic stromal lymphopoietin protein and uses thereofMATTSON JEANINE D·Filed 2010·Granted Dec 13, 2011·7 cites·18 claims
- 1283US8791242B2Canine thymic stromal lymphopoietin protein and uses thereof to treat allergic symptomsMATTSON JEANINE D·Filed 2011·Granted Jul 29, 2014·6 cites·12 claims
- 1383US7579440B2Mammalian cytokines; related reagentsSCHERING CORP·Filed 2004·Granted Aug 25, 2009·5 cites·3 claims
- 1483US7148330B2Binding compounds for IL-27SCHERING CORP·Filed 2001·Granted Dec 12, 2006·5 cites·14 claims
- 1583US6670146B2Regulatory T cells; methodsSCHERING CORP·Filed 2001·Granted Dec 30, 2003·17 cites·13 claims
- 1682US7718772B2Canine thymic stromal lymphopoietin protein and uses thereofSCHERING PLOUGH ANIMAL HEALTH·Filed 2007·Granted May 18, 2010·4 cites·18 claims
- 1782US7569224B2Mammalian cytokines; receptors; related reagents and methodsSCHERING CORP·Filed 2005·Granted Aug 4, 2009·5 cites·9 claims
- 1882US7071308B2Cytokine receptorSCHERING CORP·Filed 2004·Granted Jul 4, 2006·13 cites·2 claims
- 1981US12102681B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME LLC·Filed 2022·Granted Oct 1, 2024·0 cites·12 claims
- 2081US8512705B2Engineered anti-TSLP antibodyPRESTA LEONARD G·Filed 2012·Granted Aug 20, 2013·3 cites·4 claims
- 2181US5837232AUse of an interleukin-10 antagonist to treat a B cell mediated autoimmune disorderSCHERING CORP·Filed 1995·Granted Nov 17, 1998·30 cites·7 claims
- 2276US8691953B2Binding compounds for IL-27TIMANS JACQUELINE C·Filed 2011·Granted Apr 8, 2014·1 cites·8 claims
- 2376US8080392B2IL-D80 polynucleotidesTIMANS JACQUELINE C·Filed 2011·Granted Dec 20, 2011·1 cites·9 claims
- 2476US6319493B1Treatment of neoplastic disease with interleukin-10SCHERING CORP·Filed 2000·Granted Nov 20, 2001·3 cites·14 claims
- 2575US2025019453A1Il2rb/il2g synthetic cytokinesSYNTHEKINE INC·Filed 2024·Application pending·0 cites
- 2674US6797813B2AK155 antibodies and binding fragments thereofSCHERING CORP·Filed 2002·Granted Sep 28, 2004·6 cites·17 claims
- 2773US8178308B2Use of IL-27 agonists to increase interferon-gamma productionDE WAAL MALEFYT RENE·Filed 2007·Granted May 15, 2012·3 cites·9 claims
- 2873US8075886B2Method of treatment using an anti-IL-B50 antibodyRECHE-GALLARDO PEDRO A·Filed 2009·Granted Dec 13, 2011·2 cites·4 claims
- 2973US2024092902A1Methods for treating cancer or infection using a combination of an anti-pd-1 antibody, an anti-lag3 antibody, and an anti-tigit antibodyMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 3071US11207406B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME·Filed 2018·Granted Dec 28, 2021·0 cites·59 claims
- 3171US7906622B2IL-D80 polypeptides and IL-27SCHERING CORP·Filed 2009·Granted Mar 15, 2011·0 cites·8 claims
- 3270US7491500B2Mammalian cytokine; related reagentsSCHERING CORP·Filed 2007·Granted Feb 17, 2009·0 cites·16 claims
- 3370US7122340B2Regulatory T cells; methodsSCHERING CORP·Filed 2003·Granted Oct 17, 2006·3 cites·9 claims
- 3469US7928198B2IL-B50 polypeptideSCHERING CORP·Filed 2008·Granted Apr 19, 2011·0 cites·2 claims
- 3568US9422355B2Antibodies to IL-B50BAZAN J FERNANDO·Filed 2008·Granted Aug 23, 2016·0 cites·7 claims
- 3667US6884410B1Methods for modulating antigen-specific immune responsesSCHERING CORP·Filed 2000·Granted Apr 26, 2005·1 cites·16 claims
- 3767US2014170658A1Mammalian cytokines; related reagentsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 3866US2014335094A1Mammalian cytokines; related reagents and methodsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 3966US2010136003A1Uses of mammalian cytokine; related reagentsSCHERING CORP·Filed 2009·Application pending·0 cites
- 4064US7241438B2AK155 polypeptidesSCHERING CORP·Filed 2004·Granted Jul 10, 2007·0 cites·9 claims
- 4163US2004091970A1Mammalian cytokines; related reagents and methodsSCHERING CORP A NEW JERSEY COR·Filed 2003·Application pending·0 cites
- 4263US2023272094A1Il2rb/il2rg synthetic cytokinesSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 4363US2007048781A1Mammalian cytokines; related reagents and methodsSCHERING CORP·Filed 2006·Application pending·0 cites
- 4462US7445779B2Methods of modulating IFNy productionSCHERING CORP·Filed 2003·Granted Nov 4, 2008·2 cites·7 claims
- 4562US2014093875A1Mammalian cytokines; receptors; related reagents and methodsMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 4661US8580938B2Engineered anti-TSLP antibodyPRESTA LEONARD G·Filed 2012·Granted Nov 12, 2013·0 cites·6 claims
- 4761US2009017018A1Uses of mammalian cytokine: related reagentsSCHERING CORP·Filed 2007·Application pending·0 cites
- 4861US2014141011A1Engineered anti-tslp antibodyPRESTA LEONARD G·Filed 2013·Application pending·0 cites
- 4959US2010135998A1Combination therapy for treatment of immune disordersSCHERING CORP·Filed 2008·Application pending·0 cites
- 5058US2025333520A1Compositions and methods related to il2 receptor bindingSYNTHEKINE INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 72 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →